We are live on ! Find out more
AHCO icon

AdaptHealth

193 hedge funds and large institutions have $2.04B invested in AdaptHealth in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 70 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

321% more call options, than puts

Call options by funds: $45.2M | Put options by funds: $10.7M

61% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 18

5% more capital invested

Capital invested by funds: $1.94B → $2.04B (+$104M)

5% more funds holding

Funds holding: 184193 (+9)

2.15% more ownership

Funds ownership: 76.69%78.84% (+2.2%)

3% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 70

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
193
Holders Change
+9
Holders Change %
+4.89%
% of All Funds
3.1%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
29
Increased
68
Reduced
70
Closed
18
Calls
$45.2M
Puts
$10.7M
Net Calls
+$34.5M
Net Calls Change
-$6.03M
Name Holding Trade Value Shares
Change
Change in
Stake
RC
76
RBF Capital
California
$1.06M -$1.59M -75,000 -58%
SOADOR
77
State of Alaska Department of Revenue
Alaska
$1.03M +$8.98K +425 +0.8%
Renaissance Technologies
78
Renaissance Technologies
New York
$1.02M -$2.24M -105,800 -67%
Comerica Bank
79
Comerica Bank
Texas
$1M -$271K -12,810 -22%
YCM
80
Yousif Capital Management
Michigan
$1M -$212K -10,010 -16%
TPSF
81
Texas Permanent School Fund
Texas
$992K -$74.2K -3,509 -6%
WI
82
Wintrust Investments
Illinois
$961K
Allspring Global Investments
83
Allspring Global Investments
North Carolina
$883K +$8.33K +394 +0.9%
Citigroup
84
Citigroup
New York
$880K +$203K +9,608 +27%
JF
85
Jump Financial
Illinois
$868K -$836K -39,547 -47%
Parallax Volatility Advisers
86
Parallax Volatility Advisers
California
$821K +$903K +42,731 New
Barclays
87
Barclays
United Kingdom
$810K -$3.15M -149,123 -78%
State of Tennessee, Department of Treasury
88
State of Tennessee, Department of Treasury
Tennessee
$793K -$660K -31,219 -43%
CS
89
Candriam SCA
Luxembourg
$787K -$293K -13,876 -25%
SIM
90
SummerHaven Investment Management
Connecticut
$770K +$11.2K +530 +1%
AIG
91
American International Group
New York
$761K -$6.55K -310 -0.8%
MIM
92
MetLife Investment Management
New Jersey
$744K
AQR Capital Management
93
AQR Capital Management
Connecticut
$710K +$532K +25,149 +213%
T. Rowe Price Associates
94
T. Rowe Price Associates
Maryland
$705K -$54.7K -2,589 -7%
LSERS
95
Louisiana State Employees Retirement System
Louisiana
$702K -$2.11K -100 -0.3%
Boston Partners
96
Boston Partners
Massachusetts
$695K -$336K -15,901 -31%
Deutsche Bank
97
Deutsche Bank
Germany
$683K +$117K +5,542 +18%
NYLIM
98
New York Life Investment Management
New York
$680K +$80.3K +3,798 +12%
AB
99
Amalgamated Bank
New York
$659K +$3.87K +183 +0.5%
CP
100
Covenant Partners
Tennessee
$658K +$42 +2 +0%

AHCO Hedge Fund Activity: Q4 2022 in Review

193 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q4 2022, worth a combined $2.04B — up 5.4% from $1.94B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new AHCO positions and 18 closed out — a net gain of 11 holders — while 68 added to existing stakes and 70 trimmed.

The largest buyer was Truist Financial, adding an estimated $74.4M. The largest seller was Silvercrest Asset Management, cutting an estimated $20.9M.

  • 193 institutional investors held AdaptHealth (AHCO) as of Q4 2022, up from 184 in Q3 2022.
  • Funds reported $2.04B of AdaptHealth stock for Q4 2022, up 5.4% quarter-over-quarter.
  • 29 funds opened new AdaptHealth positions in Q4 2022 and 18 closed out, a net change of +11 holders.
  • The largest AdaptHealth buyer in Q4 2022 was Truist Financial, an estimated $74.4M added.
  • The largest AdaptHealth seller in Q4 2022 was Silvercrest Asset Management, an estimated $20.9M sold.

Based on aggregated 13F filings for Q4 2022.